RT Journal Article
SR Electronic
T1 Global RNAseq of ocular cells reveals gene dysregulation in both asymptomatic and with Congenital Zika Syndrome infants exposed prenatally to Zika virus
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.20.20214403
DO 10.1101/2020.10.20.20214403
A1 Rosa-Fernandes, Livia
A1 Bedrat, Amina
A1 dos Santos, Maria Luiza B.
A1 Pinto, Ana
A1 Lucena, E
A1 Silva, Thiago P.
A1 Melo, Rossana C. N.
A1 Palmisano, Giuseppe
A1 Cardoso, Claudete Araújo
A1 Barbosa, Raquel Hora
YR 2020
UL http://medrxiv.org/content/early/2020/10/23/2020.10.20.20214403.1.abstract
AB In 2015, Brazil reported an outbreak identified as Zika virus (ZIKV) infection associated with congenital abnormalities. To date, a total of 86 countries and territories have described evidence of Zika infection and recently the appearance of the African ZIKV lineage in Brazil highlights the risk of a new epidemic. The spectrum of ZIKV infection-induced alterations at both cellular and molecular levels is not completely elucidated. Here, we present for the first time the gene expression responses associated with prenatal ZIKV infection from ocular cells. We applied a recently developed non-invasive method (impression cytology) which use eye cells as a model for ZIKV studies. The ocular profiling revealed significant differences between exposed and control groups, as well as a different pattern in ocular transcripts from Congenital Zika Syndrome (CZS) compared to ZIKV-exposed but asymptomatic infants. Our data showed pathways related to mismatch repair, cancer, and PI3K/AKT/mTOR signaling and genes probably causative or protective in the modulation of ZIKV infection. Ocular cells revealed the effects of ZIKV infection on primordial neuronal cell genes, evidenced by changes in genes associated with embryonic cells. The changes in gene expression support an association with the gestational period of the infection and provide evidence for the resulting clinical and ophthalmological pathologies. Additionally, the findings of cell death- and cancer-associated deregulated genes raise concerns about the early onset of other potential pathologies including the need for tumor surveillance. Our results thus provide direct evidence that infants exposed prenatally to the Zika virus, not only with CZS but also without clinical signs (asymptomatic) express cellular and molecular changes with potential clinical implications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis pilot study was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ, Brazil, Proc. nO. 201.779.2017. PDS.2017, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil. RCNM and GP, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG, Brazil, CBB.APQ.03647.16.RCNM and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil, Proc. nO. 2014.06863.3, 2018.18257.1, 2018.15549.1. RH Barbosa was a recipient of a Brazilian FAPERJ senior postdoctoral fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was carried out in accordance with the ethical principles taken from the Declaration of Helsinki and written informed consent was obtained from the parents of babies under Institutional Review Board and Ethics Committee of Universidade Federal Fluminense approved protocols (approved protocols register number - CAAE: 79890517.6.0000.5243).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for this study have been deposited in the European Nucleotide Archive at EMBL EBI under accession number PRJEB40869. Additional data supporting the findings of this study are available within the article and its Supplemental files or are available from the authors upon request. Due to privacy and consent restrictions, individualized RNAseq data files cannot be uploaded publicly, but might be available to researchers upon request and signature of a Data Use Agreement. https://www.ebi.ac.uk/ena/browser/view/PRJEB40869